MiR-21 functionally interacts with the 3'UTR of chemokine CCL20 and down-regulates CCL20 expression in miR-21 transfected colorectal cancer cells

Cancer Letters

Volumn 316, Issue 1, 2012, Pages 105-112

  Vicinus, Benjamin ^a   Rubie, Claudia ^a   Faust, Sabrina K ^a   Frick, Vilma Oliveira ^a   Ghadjar, Pirus ^b   Wagner, Mathias ^a   Graeber, Stefan ^a   Schilling, Martin K ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

CCL20; Chemokines; CRC; MicroRNA; MiR 21

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MICRORNA 21;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN NUCLEIC ACID INTERACTION; PROTEIN TARGETING; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS;

3' UNTRANSLATED REGIONS; CACO-2 CELLS; CELL LINE, TUMOR; CHEMOKINE CCL20; COLORECTAL NEOPLASMS; DOWN-REGULATION; HUMANS; MICRORNAS; MUTAGENESIS, SITE-DIRECTED; RNA, MESSENGER; TRANSFECTION;

EID: 84855353486     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.10.031     Document Type: Article

References (41)

1. Huntzinger E., Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet. 2011, 12:99-110.
2. Carthew R.W., Sontheimer E.J. Origins and mechanisms of miRNAs and siRNAs. Cell 2009, 136:642-655.
3. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
4. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight. Nat. Rev. Genet. 2008, 9:102-114.
5. Wu L., Belasco J.G. Let me count the ways: mechanisms of gene regulation by miRNA s and siRNAs. Mol. Cell 2008, 29:1-7.
6. Cowland J.B., Hother C., Grønbaek K. MicroRNAs and cancer. APMIS 2007, 115:1090-1106.
7. Stark A., Brennecke J., Bushati N., Russelo R.B., Cohen S.M. Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution. Cell 2005, 123:1133-1146.
8. Kumar M.S., Erkeland S.J., Pester R.E., Chen C.Y., Ebert M.S., Sharp P.A., Jacks T. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc. Natl. Acad. Sci. USA 2008, 105:3903-3908.
9. Medina P.P., Nolde M., Slack F.J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010, 467:86-90.
10. Cummins J.M., He Y., Leary R.J., Pagliarini R., Diaz L.A., Sjoblom T., Barad O., Bentwich Z., Szafranska A.E., Labourier E., Raymond C.K., Roberts B.S., Juhl H., Kinzler K.W., Vogelstein B., Velculescu V.E. The colorectal microRNAome. Proc. Natl. Acad. Sci. USA 2006, 103:3687-3692.
11. Bandrés E., Cubedo E., Agirre X., Malumbres R., Zárate R., Ramirez N., Abajo A., Navarro A., Moreno I., Monzó M., García-Foncillas J. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer 2006, 5:29.
12. Balaguer F., Link A., Lozano J.J., Cuatrecasas M., Nagasaka T., Boland C.R., Goel A. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res. 2010, 70:6609-6618.
13. Rubie C., Oliveira V., Kempf K., Wagner M., Tilton B., Rau B., Kruse B., König J., Schilling M. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Tumour Biol. 2006, 27:166-174.
14. Ghadjar P., Coupland S.E., Na I.K., Noutsias M., Letsch A., Stroux A., Bauer S., Buhr H.J., Thiel E., Scheibenbogen C., Keilholz U. Chemokine receptor CCR6 expression level and liver metastasis in colorectal cancer. J. Clin. Oncol. 2006, 24:1910-1916.
15. Ghadjar P., Rubie C., Aebersold D.M., Keilholz U. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int. J. Cancer 2009, 125:741-745.
16. Bustin S.A. Absolute quantification of mRNA using real time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 2000, 25:169-193.
17. Rubie C., Kempf K., Hans J., Su T., Tilton B., Georg T., Brittner B., Ludwig B., Schilling M. Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues. Mol. Cell Probes 2005, 19:101-109.
18. Yang C.C., Ogawa H., Dwinell M.B., McCole D.F., Eckmann L., Kagnoff M.F. Chemokine receptor CCR6 transduces signals that activate p130Cas and alter cAMP-stimulated ion transport in human intestinal epithelial cells. Am. J. Physiol. Cell Physiol. 2005, 288:C321-328.
19. Brand S., Olszak T., Beigel F., Diebold J., Otte J.M., Eichhorst S.T., Göke B., Dambacher J. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. J. Cell. Biochem. 2006, 97:709-723.
20. Blenkiron C., Goldstein L.D., Thorne N.P., Spiteri I., Chin S.F., Dunning M.J., Barbosa-Morais N.L., Teschendorff A.E., Green A.R., Ellis I.O., Tavaré S., Caldas C., Miska E.A. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 2007, 8:R214.
21. Mattie M.D., Benz C.C., Bowers J., Sensinger K., Wong L., Scott G.K., Fedele V., Ginzinger D., Getts R., Haqq C. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol. Cancer 2006, 5:24.
22. Kuhn D.E., Martin M.M., Feldman D.S., Terry A.V., Nuovo G.J., Elton T.S. Experimental validation of miRNA targets. Methods 2008, 44:47-54.
23. Bentwich I. Prediction and validation of microRNAs and their targets. FEBS Lett. 2005, 579:5904-5910.
24. Mazière P., Enright A.J. Prediction of microRNA targets. Drug Discov. Today 2007, 12:452-458.
25. Brennecke J., Stark A., Russell R.B., Cohen S.M. Principles of micro-RNA-target recognition. PLoS Biol. 2005, 3:e85.
26. Yang H., Kong W., He L., Zhao J.J., O'Donnell J.D., Wang J., Wenham R.M., Coppola D., Kruk P.A., Nicosia S.V., Cheng J.Q. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 2008, 68:425-433.
27. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658.
28. Zhu S., Si M.L., Wu H., Mo Y.Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem. 2007, 282:14328-14336.
29. Ruike Y., Ichimura A., Tsuchiya S., Shimizu K., Kunimoto R., Okuno Y., Tsujimoto G. Global correlation analysis for micro-RNA and mRNA expression profiles in human cell lines. J. Human Genet. 2008, 53:515-523.
30. Nicolas F.E. Experimental validation of microRNA targets using a luciferase reporter system. Methods Mol. Biol. 2011, 732:139-152.
31. Szczyrba J., Löprich E., Wach S., Jung V., Unteregger G., Barth S., Grobholz R., Wieland W., Stöhr R., Hartmann A., Wullich B., Grässer F. The microRNA profile of prostate carcinoma obtained by deep sequencing. Mol. Cancer Res. 2010, 8:529-538.
32. Yi Y.h., Sun X.S., Qin J.M., Zhao Q.H., Liao W.P., Long Y.S. Experimental identification of microRNA targets on the 3' untranslated region of human FMR1 gene. J Neurosci Methods 2010, 190:34-38.
33. Jennewein C., von Knethen A., Schmid T., Brüne B. MicroRNA-27b contributes to lipopolysaccharide-mediated peroxisome proliferator-activated receptor gamma (PPARgamma) mRNA destabilization. J. Biol. Chem. 2010, 285:11846-11853.
34. Hutvágner G., Zamore P.D. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002, 297:2056-2060.
35. Sun W., S Julie Li Y., Huang H.D., Shyy J.Y., Chien S. MicroRNA: a master regulator of cellular processes for bioengineering systems. Annu. Rev. Biomed. Eng. 2010, 12:1-27.
36. Kawano S., Nakamachi Y. miR-124a as a key regulator of proliferation and MCP-1 secretion in synoviocytes from patients with rheumatoid arthritis. Ann. Rheum. Dis. 2011, 70(Suppl 1):i88-91.
37. Hu N., Zhang J., Cui W., Kong G., Zhang S., Yue L., Bai X., Zhang Z., Zhang W., Zhang X., Ye L. miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8. J. Biol. Chem. 2011, 13714-13722.
38. Pillai M.M., Yang X., Balakrishnan I., Bemis L., Torok-Storb B. MiR-886-3p down regulates CXCL12 (SDF1) expression in human marrow stromal cells. PLoS One 2010, 5:e14304.
39. Rom S., Rom I., Passiatore G., Pacifici M., Radhakrishnan S., Del Valle L., Piña-Oviedo S., Khalili K., Eletto D., Peruzzi F. CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J. 2010, 24:2292-2300.
40. Asangani I.A., Rasheed S.A., Nikolova D.A., Leupold J.H., Colburn N.H., Post S., Allgayer H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008, 27:2128-2136.
41. Wang P., Zou F., Zhang X., Li H., Dulak A., Tomko R.J., Lazo J.S., Wang Z., Zhang L., Yu J. microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res. 2009, 69:8157-8165.